Questions across 2 calls

Deekshant Boolchandani

DB Wealth

Caplin Point Laboratories Limited

Caplin Point Laboratories Limited CC-Sep25.pdf · 2025-11-06

Congratulations on the good numbers, sir. First question is you were traveling to China as you spoke in the last quarter. And we already have a plan in place to do our backward integration better and set up a better distribution channel, so that we can expand our market. And you have said that, we can expect the 20%, 25% growth in the next, let's say, 2 years. Yes, what about further than that? What is it that we are looking at? Because we are a visionary company. And what is it that we are looking at after that?

Okay. So just to dig a bit deeper, sir. One, it's amazing and inspiring what you're doing at the age of 70, sir. It's really inspiring.

SAGILITY LIMITED

SAGILITY LIMITED CC-Dec24.pdf · 2025-02-05

Hi, so can you paint a picture for us that what are the kind of opportunities that you are looking for the U.S. government? Because I'm sure the company has thought about, the changes that the government might make, so what are the opportunities that if we see , we will bounce on them? They are clearly focused on Healthcare. Do you think it's going to be a cost accretive or a growth accretive?

To specify my question a little bit – Trump has lately appointed Kennedy as a Health Care Chief of sorts to make sure that the Healthcare has been taken care of U.S. Do you think this Healthcare spend that they might do or a readjustment of spend ? Is it going to be beneficial for us, or do you think that there is a particular opportunity that we can see in this segment that will now be developing?